1-(4-((1H-pyrazol-1-yl)methyl)benzyl)-N-((1-amino-5-methylisoquinolin-6-yl)methyl)-3-(methoxymethyl)-1H-pyrazole-4-carboxamide

ID: ALA5284044

Max Phase: Preclinical

Molecular Formula: C28H29N7O2

Molecular Weight: 495.59

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COCc1nn(Cc2ccc(Cn3cccn3)cc2)cc1C(=O)NCc1ccc2c(N)nccc2c1C

Standard InChI:  InChI=1S/C28H29N7O2/c1-19-22(8-9-24-23(19)10-12-30-27(24)29)14-31-28(36)25-17-35(33-26(25)18-37-2)16-21-6-4-20(5-7-21)15-34-13-3-11-32-34/h3-13,17H,14-16,18H2,1-2H3,(H2,29,30)(H,31,36)

Standard InChI Key:  PHIJQNWPPQPKQQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
    0.9744    3.5731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5619    2.8586    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9744    2.1441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5619    1.4296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9742    0.7155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7992    0.7155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2116    0.0010    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0367    0.0010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4492   -0.7136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2742   -0.7136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6849   -1.4263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2722   -2.1410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4513   -2.1410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0349   -1.4309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6868   -2.8585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5115   -2.8585    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9204   -2.1416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5076   -1.4263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2743   -3.5731    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6868    0.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2116    1.4300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4223    0.1027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3309    0.4381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2446    1.2582    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0453    0.0256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7598    0.4381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4699    0.0263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1864    0.4344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1864    1.2629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4717    1.6752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7598    1.2633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9008    1.6754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6154    1.2629    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7015    0.4429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5081    0.2714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9204    0.9855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3686    1.5984    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10  9  2  0
 11 10  1  0
 12 11  2  0
 13 12  1  0
 14 13  2  0
  9 14  1  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 11 18  1  0
 15 19  1  0
 10 20  1  0
  6 21  2  0
  5 22  2  0
 22 23  1  0
 24  4  2  0
 24 23  1  0
 25 23  1  0
 26 25  1  0
 27 26  1  0
 28 27  2  0
 29 28  1  0
 30 29  2  0
 26 31  2  0
 31 30  1  0
 32 29  1  0
 33 32  1  0
 34 33  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5284044

    ---

Associated Targets(Human)

KLKB1 Tclin Plasma kallikrein (2047 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 495.59Molecular Weight (Monoisotopic): 495.2383AlogP: 3.69#Rotatable Bonds: 9
Polar Surface Area: 112.88Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.13CX Basic pKa: 7.11CX LogP: 3.08CX LogD: 2.91
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.32Np Likeness Score: -1.34

References

1. Xie Z, Li Z, Shao Y, Liao C..  (2020)  Discovery and development of plasma kallikrein inhibitors for multiple diseases.,  190  [PMID:32066009] [10.1016/j.ejmech.2020.112137]

Source